News articles about iKang Healthcare Group (NASDAQ:KANG) have been trending positive on Wednesday, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. iKang Healthcare Group earned a media sentiment score of 0.46 on Accern’s scale. Accern also assigned media headlines about the medical research company an impact score of 47.4318805945106 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Several analysts recently issued reports on KANG shares. BidaskClub raised shares of iKang Healthcare Group from a “hold” rating to a “buy” rating in a report on Saturday, March 10th. ValuEngine raised shares of iKang Healthcare Group from a “sell” rating to a “hold” rating in a report on Monday, April 2nd.
KANG remained flat at $$20.50 during trading on Wednesday. 158,830 shares of the company traded hands, compared to its average volume of 687,964. iKang Healthcare Group has a 1 year low of $11.70 and a 1 year high of $20.62. The company has a quick ratio of 0.68, a current ratio of 0.70 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $1.42 billion, a PE ratio of 78.85 and a beta of 0.07.
iKang Healthcare Group Company Profile
iKang Healthcare Group, Inc, together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company operates in two segments, Medical Examinations and Other Medical Services, and Dental Services. It offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items.
Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.